21 results match your criteria: "Christchurch Hospital and Christchurch School of Medicine.[Affiliation]"
ANZ J Surg
January 2020
Department of Surgery, Deakin University and Barwon Health, Geelong, Victoria, Australia.
BMJ
August 2014
Social and Community Health and Centre for Addiction Research, University of Auckland, New Zealand.
N Z Med J
September 2010
Department of Vascular, Endovascular and Transplant Surgery, Christchurch Hospital and Christchurch School of Medicine, University of Otago, PO Box 4345, Christchurch, New Zealand.
Aims: 30-40% of individuals will be affected by varicose veins during their lifetime. Many will contemplate treatment and will access the (Inter)net for information. The aim of this study is to determine whether New Zealand-based websites are an accurate source of information for the public.
View Article and Find Full Text PDFClin Gastroenterol Hepatol
June 2008
Department of Medicine, Christchurch Hospital and Christchurch School of Medicine, Christchurch, New Zealand.
Background & Aims: Patients with inflammatory bowel disease (IBD) may have different thiopurine dose requirements in relation to thiopurine methyltransferase (TPMT) genotype and/or phenotype. The purpose of this study was to determine thiopurine dose requirements in intermediate versus normal TPMT metabolism status.
Methods: Consecutive patients starting azathioprine or 6-mercaptopurine for IBD were followed up for 9 months.
Br J Clin Pharmacol
October 2006
Department of Clinical Pharmacology, Christchurch Hospital and Christchurch School of Medicine, Private Bag, Christchurch, New Zealand.
Background: The association between thiopurine methyltransferase (TPMT) deficiency and myelosuppression with azathioprine is well recognized. Two cases are presented that illustrate the very different outcomes that may occur with azathioprine in patients with TPMT deficiency, which affects 0.3-0.
View Article and Find Full Text PDFBr J Clin Pharmacol
October 2006
Department of Clinical Pharmacology, Christchurch Hospital and Christchurch School of Medicine, Christchurch, New Zealand.
Aims: To determine infant exposure to 6-thioguanine and 6-methylmercaptopurine nucleotides (6-TGN and 6-MMPN, respectively) during maternal use of azathioprine in breastfeeding.
Methods: Mother-infant pairs provided blood for determination of 6-TGN and 6-MMPN concentrations, and TPMT genotype.
Results: Four women taking azathioprine 1.
Anaesth Intensive Care
April 2006
Department of Anaesthesia, Christchurch Hospital and Christchurch School of Medicine, Christchurch, New Zealand.
We have previously shown that a model of anaesthetic uptake and distribution, developed for use as a teaching tool, is able to predict end-tidal isoflurane and sevoflurane concentrations at least as well as commonly used propofol models predict blood levels of propofol. Models with good predictive performance may be useful as part of real-time prediction systems. The aim of this study was to assess the performance of this model with desflurane.
View Article and Find Full Text PDFBr J Clin Pharmacol
January 2006
Department of Clinical Pharmacology, Christchurch Hospital and Christchurch School of Medicine, Christchurch, New Zealand.
Aims: To determine the milk-to-plasma (M/P) concentration ratio of celecoxib, and estimate likely infant exposure.
Methods: Blood and milk were sampled for 48 h after oral administration of celecoxib 200 mg to six lactating volunteers. The M/P ratio was derived from the area under the concentration-time curves (0-infinity) and the infant 'dose' estimated from celecoxib concentrations in milk.
Anesth Analg
October 2004
Department of Anaesthesia, Christchurch Hospital and Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand.
We have shown that a multicompartment model accurately predicts end-tidal (ET) sevoflurane (sevo) and isoflurane concentrations. The model has been adapted to use real-time fresh gas flow and vaporizer settings to display a 10-min prediction of ET sevo concentrations. In this study, we evaluated the effect of the predictive display on the speed and accuracy of changes in ET sevo by the anesthesiologist.
View Article and Find Full Text PDFDis Colon Rectum
March 2004
Department of Gastroenterology, Christchurch Hospital and Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand.
Background: Patients with chronic ulcerative colitis and Crohn's colitis have an increased risk of colorectal cancer. Because of this, surveillance colonoscopy is practiced.
Aims: We aimed to describe the practice of surveillance colonoscopy in New Zealand, with comparison among specialties, and with practice internationally.
Intern Med J
April 2001
The Christchurch Cardioendocrine Research Group, Christchurch Hospital and Christchurch School of Medicine, New Zealand.
Psychopharmacology (Berl)
June 2001
Department of Endocrinology, Christchurch Hospital and Christchurch School of Medicine, New Zealand.
Rationale: Subjects with depression may exhibit activation of the hypothalamic-pituitary-adrenal (HPA) axis, but little is known about the response of basal hormone levels to antidepressant therapy.
Objectives: To determine whether treatment of depression with standard antidepressant medications resulted in reductions in basal activity of afternoon cortisol, ACTH and AVP. A secondary aim was to examine whether there was any difference in hormonal response between an SSRI (fluoxetine) and a tricyclic antidepressant (nortriptyline).
Int Immunol
July 2001
Haematology/Immunology Research Group, Christchurch Hospital and Christchurch School of Medicine, Christchurch, New Zealand.
CD83 is an inducible glycoprotein expressed predominantly by dendritic cells (DC) and B lymphocytes. Expression of membrane CD83 (mCD83) is widely used as a marker of differentiated/activated DC but its function and ligand(s) are presently unknown. We report the existence of a soluble form of CD83 (sCD83).
View Article and Find Full Text PDFN Z Med J
April 2001
Department of Paediatrics, Christchurch Hospital and Christchurch School of Medicine.
Aims: To evaluate the short and long term morbidity of gastrostomy insertion, and to identify ongoing management requirements.
Methods: A retrospective review was undertaken of the hospital casenotes of children aged up to fifteen years who had a gastrostomy placed in Christchurch over a six year period to March 1998.
Results: 42 children had a gastrostomy fashioned, 35 in the last three years of the period reviewed.
J Gastroenterol Hepatol
September 2000
Department of Gastroenterology, Christchurch Hospital and Christchurch School of Medicine, New Zealand.
Background And Aims: Although coeliac disease is a common condition, the role of population screening is not clear. The aim of this study was to determine the prevalence and clinical significance of coeliac disease in the adult population of Christchurch, New Zealand.
Methods: A total of 1064 adults randomly selected from the 1996 Christchurch electoral rolls were enlisted.
Hypertension
October 2000
Christchurch Cardioendocrine Research Group, Christchurch Hospital and Christchurch School of Medicine, Christchurch, New Zealand.
We examined the effects of the vasodilator peptide adrenomedullin (AM) infused intravenously into subjects with essential hypertension. Eight men 39 to 58 years old with uncomplicated hypertension (147/96+/-5/3 mm Hg at baseline) were studied in a placebo-controlled, crossover design. Each subject received intravenous AM in a low and a high dose (2.
View Article and Find Full Text PDFHypertension
October 2000
Christchurch Cardioendocrine Research Group, Christchurch Hospital and Christchurch School of Medicine, Christchurch, New Zealand.
Omapatrilat is a member of the new drug class of vasopeptidase inhibitors that may offer benefit in the treatment of heart failure (HF) through simultaneous inhibition of angiotensin-converting enzyme and neutral endopeptidase. We examined the effects of omapatrilat in a placebo-controlled crossover study using a pacing model of HF. Seven sheep were paced sequentially at 180 bpm (mild HF) and then 225 bpm (severe HF) for 7 days each.
View Article and Find Full Text PDFJ Clin Endocrinol Metab
March 2000
The Christchurch Cardioendocrine Research Group, Christchurch Hospital and Christchurch School of Medicine, New Zealand.
The actions of adrenomedullin (ADM), a 52-amino acid peptide, are not well defined in man. We, therefore, studied eight normal volunteers aged 1832 yr in a placebo-controlled crossover study. On the 2 study days, subjects received, in random order, ADM in "low" and "high" dose (2.
View Article and Find Full Text PDFAJR Am J Roentgenol
September 1999
Department of Radiology, Christchurch Hospital and Christchurch School of Medicine, University of Otago, New Zealand.
Objective: During a study of infants who were being examined for antenatal renal dilatation, we noted that many had growth lines in their proximal femur on postnatal radiographs. We decided to determine the prevalence of growth lines in healthy infants.
Materials And Methods: Voiding cystourethrograms of 791 neonates and infants, 0-6 months old, were reviewed.
J Invest Dermatol
November 1998
Haematology/Immunology Research Group, Christchurch Hospital and Christchurch School of Medicine, New Zealand.
The CMRF-44 and CD83 (HB15) antigens are associated with functional maturation and activation of blood dendritic cells (DC). We describe the expression of these antigens on freshly isolated epidermal Langerhans cells and dermal DC as well as the distribution of CD83+/ CMRF-44++-activated DC within sections of normal human skin. Fresh Langerhans cells were prepared by standard techniques and large numbers of enriched (25%-55%), viable dermal DC were obtained using an improved collagenase treatment protocol with density gradient enrichment.
View Article and Find Full Text PDFEur J Immunol
June 1996
Haematology/Immunology Research Group, Christchurch Hospital and Christchurch School of Medicine, New Zealand.
The CD40:CD40 ligand (CD40L) interaction provides T lymphocyte-mediated help for B lymphocyte and monocyte function but has also been shown to serve as a co-stimulus for T lymphocyte activation. In this report, we studied the regulation of CD40 expression and its functional relevance for the human dendritic cell (DC) stimulation of T lymphocytes. Only a small subpopulation of directly isolated blood DC expressed CD40.
View Article and Find Full Text PDF